Mr. King is a respected senior healthcare leader who operates with a strong emphasis on deeply understanding the healthcare industry, strategic planning, “playing the long game,” and staying ahead of rapidly evolving industry trends and challenges. He uses the insights gained in his 20+ year career as a healthcare leader in providing strategic and operational advice to a number of industry stakeholders.
Mr. King most recently served as executive chair and CEO of Laboratory Corporation of America Holdings (Labcorp – NYSE: LH). Under his leadership, Labcorp transformed from a pure-play U.S. testing laboratory into a leading global life sciences company — tripling in size through a combination of organic growth and strategic acquisitions, entering the Fortune 500, and being named to Fortune’s List of World’s Most Admired Companies. It is now the world’s largest clinical laboratory and second-largest drug development business. In 2019, Forbes named Mr. King to its list of America’s Most Innovative Leaders. Prior to joining Labcorp, Mr. King was partner at Hogan & Hartson LLP (now Hogan Lovells) where he was a key leader in the firm’s healthcare fraud and abuse practice, representing national healthcare companies in investigations and litigation. Mr. King was also an Assistant U.S. Attorney for the District of Maryland.
Mr. King is the Executive Chairman of ScribeAmerica, a leading provider of healthcare workforce solutions; is the non-executive chairman of Privia Health (NASDAQ: PRVA); and also serves on the boards of ZimVie (NASDAQ: ZIMV), binx health, and VaxCare. Mr. King’s extensive commitment to community service also includes serving as board chair of PATH, a nonprofit global health organization; board member of Novant Health, a multi-state integrated health system; member of the advisory board and executive committee of Duke University’s Robert J. Margolis, MD, Center for Health Policy; and board member of The Emily K Center, a college-readiness center founded by Duke coach Mike Krzyzewski. Mr. King previously served on the board of Cardinal Health (NYSE: CAH), a Fortune 20 healthcare company, and the American Clinical Laboratory Association, where he served as board chair from 2010 to 2014.
Mr. King holds a bachelor’s degree, cum laude, from Princeton University and a Juris Doctor, cum laude, from the University of Pennsylvania Law School.